Ex vivo generation of human alloantigen-specific regulatory T cells from CD4(pos)CD25(high) T cells for immunotherapy
about
Regulatory T Cells: Serious Contenders in the Promise for Immunological Tolerance in TransplantationRegulatory T-cell therapy in transplantation: moving to the clinicRequirement of cognate CD4+ T-cell recognition for the regulation of allospecific CTL by human CD4+ CD127- CD25+ FOXP3+ cells generated in MLR.Clinical grade Treg: GMP isolation, improvement of purity by CD127 Depletion, Treg expansion, and Treg cryopreservationVasoactive intestinal peptide induces cell cycle arrest and regulatory functions in human T cells at multiple levels.Clinical grade manufacturing of human alloantigen-reactive regulatory T cells for use in transplantation.Generation, cryopreservation, function and in vivo persistence of ex vivo expanded cynomolgus monkey regulatory T cells.Expansion of antigen-specific regulatory T cells with the topical vitamin d analog calcipotriol.Prevention of allograft rejection by amplification of Foxp3(+)CD4(+)CD25(+) regulatory T cellsMassive ex vivo expansion of human natural regulatory T cells (T(regs)) with minimal loss of in vivo functional activity.Transferred WT1-reactive CD8+ T cells can mediate antileukemic activity and persist in post-transplant patients.Human regulatory T cells with alloantigen specificity are more potent inhibitors of alloimmune skin graft damage than polyclonal regulatory T cells.Attenuation of donor-reactive T cells allows effective control of allograft rejection using regulatory T cell therapy.Immunotherapy with regulatory T cells in transplantation.T regulatory cells and the control of alloimmunity: from characterisation to clinical application.CD4+ regulatory T cells in solid organ transplantation.Natural and expanded CD4(+)CD25(+) regulatory T cells in bone marrow transplantationRelevance of regulatory T cell promotion of donor-specific tolerance in solid organ transplantation.New ways to separate graft-versus-host disease and graft-versus-tumour effects after allogeneic haematopoietic stem cell transplantation.Regulatory T cell induction, migration, and function in transplantation.Molecular monitoring for rejection and graft outcome in kidney transplantation.Induction of transplantation tolerance through regulatory cells: from mice to men.Regulatory T cells: tolerance induction in solid organ transplantation.Pharmacologic targeting of regulatory T cells for solid organ transplantation: current and future prospects.Cell Therapy in Kidney Transplantation: Focus on Regulatory T Cells.Obtaining regulatory T cells from uraemic patients awaiting kidney transplantation for use in clinical trials.Food-allergic infants have impaired regulatory T-cell responses following in vivo allergen exposure.Large-scale in vitro expansion of human regulatory T cells with potent xenoantigen-specific suppression.Single CD28 stimulation induces stable and polyclonal expansion of human regulatory T cells.Human regulatory macrophages are potent in suppression of the xenoimmune response via indoleamine-2,3-dioxygenase-involved mechanism(s).Generation of Human Alloantigen-Specific Regulatory T Cells Under Good Manufacturing Practice-Compliant Conditions for Cell Therapy.Combination of IL-2, rapamycin, DNA methyltransferase and histone deacetylase inhibitors for the expansion of human regulatory T cells.Generation and Characterization of Alloantigen-Specific Regulatory T Cells For Clinical Transplant Tolerance.Optimizing human Treg immunotherapy by Treg subset selection and E-selectin ligand expression.T follicular helper cells: a potential therapeutic target in follicular lymphoma.Clinical Grade Regulatory CD4+ T Cells (Tregs): Moving Toward Cellular-Based Immunomodulatory Therapies.A Rapamycin-Based GMP-Compatible Process for the Isolation and Expansion of Regulatory T Cells for Clinical Trials.An Autocrine TNFα-Tumor Necrosis Factor Receptor 2 Loop Promotes Epigenetic Effects Inducing Human Treg Stability In Vitro.Comparative study of regulatory T cells expanded ex vivo from cord blood and adult peripheral bloodAdoptive transfer of xenoantigen‑stimulated T cell receptor Vβ‑restricted human regulatory T cells prevents porcine islet xenograft rejection in humanized mice
P2860
Q26784460-CA5E6A14-DC45-4CD2-A59B-91614B61D47BQ27025869-67795E69-2689-440E-B0E5-DDE536E0415CQ31027865-28D584A3-54BA-4228-B6E8-620103BD6A19Q33367565-FF5A0ED6-7FFD-409A-B414-7E559CF8A199Q33826520-845B1A99-B3A3-4F31-97F7-EC2FC256D20DQ34038443-A6A53513-9FBB-4F27-BFB0-DFF8F1415D59Q35514307-9986EF5E-DA3E-4AA4-8671-5BECDCC65338Q36066638-22AEAEB2-C423-47C0-997E-FCB4F00C7DF7Q36127345-8C5BB41C-E174-40D2-8FE8-5E26EEBF21EEQ36551599-1111D3AF-3991-443C-9C01-22FC228CAF6CQ36919619-BDC3CCEB-0A5C-40C0-B3DB-5E2CEC9DDFF0Q37180691-42D9C632-820A-4BAA-94F2-063311CB664CQ37603816-9FDFEF67-C150-46C8-BA9F-BE033DFA795CQ37773304-F322D02E-BA20-4C8B-AE30-A56DF6AF8F1EQ37792312-A0C6327B-D30E-467C-BCE6-73432C5B0604Q37794623-2F14FD4F-7CEC-46AA-BAE0-002B357521F9Q37824995-BBDD3195-9C78-45CF-AABD-7F03A517C702Q38027504-734B6881-9FEC-46D1-BC33-A9620F99ECB3Q38057376-F9113556-44B9-45D8-85B6-0292DBCD3CB9Q38057738-8CC1EC42-2AE8-44C5-AF52-6AE0BB0DC5F7Q38089948-EEC0ECA5-19D7-448E-882E-5B6D08280B95Q38187170-18066B14-4CF2-4E17-AD36-4023AADA50FAQ38557841-24D6F052-B64F-4C8C-B144-78A1A0792C01Q38614123-EFB16DAC-A629-48B1-9FD7-2A10B38A4827Q39279238-8D9FBFBB-8107-4748-9D83-B5424E28D003Q39431833-9FB384E8-75C2-4103-AAB1-1D50E6BB683BQ40443439-A11FB34B-15F4-4F36-B35C-6AE3E123E58BQ41531533-FDC48FDD-520A-4D28-A3FA-D126ECD11750Q41791447-DE7F4320-930D-4756-86C6-2D5554639A58Q45870394-8D124448-B8B0-480D-BAC9-FB5ADFDE147AQ46059376-79A44281-CC8B-4586-B6C6-6BE8A424602CQ47118146-859544D2-014D-4A66-B3F9-FBDAF30B98B1Q48215037-79B66264-D6B5-4079-9FB2-10049702443BQ49702312-85178A1C-DEBB-4548-9DF9-A4990B00C566Q49702451-C8D3BC31-1956-46F0-88BB-C8EB9994B964Q52682313-C77737F9-A6A0-4454-93C0-4BBEB25891D6Q52725822-57CA36C8-9E98-4A59-91B0-F1CC576B35FFQ55027907-7EB0EA10-308A-47F1-9034-73BCC8572C43Q56898066-645D95EF-2325-4FAC-8084-6573852D0579Q58752977-16828D08-1E07-4034-B318-0BA5FFAAF408
P2860
Ex vivo generation of human alloantigen-specific regulatory T cells from CD4(pos)CD25(high) T cells for immunotherapy
description
2008 nî lūn-bûn
@nan
2008 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Ex vivo generation of human alloantigen-specific regulatory T cells from CD4
@nl
Ex vivo generation of human al ...... igh) T cells for immunotherapy
@ast
Ex vivo generation of human al ...... igh) T cells for immunotherapy
@en
type
label
Ex vivo generation of human alloantigen-specific regulatory T cells from CD4
@nl
Ex vivo generation of human al ...... igh) T cells for immunotherapy
@ast
Ex vivo generation of human al ...... igh) T cells for immunotherapy
@en
prefLabel
Ex vivo generation of human alloantigen-specific regulatory T cells from CD4
@nl
Ex vivo generation of human al ...... igh) T cells for immunotherapy
@ast
Ex vivo generation of human al ...... igh) T cells for immunotherapy
@en
P2093
P2860
P1433
P1476
Ex vivo generation of human al ...... igh) T cells for immunotherapy
@en
P2093
Hans J P M Koenen
Irma Joosten
Jorieke H Peters
P2860
P356
10.1371/JOURNAL.PONE.0002233
P407
P577
2008-05-21T00:00:00Z